Immunogenicity: Clouding the Future of Intravitreal Therapy

Ocul Immunol Inflamm. 2023 Nov;31(9):1746-1749. doi: 10.1080/09273948.2022.2139273. Epub 2022 Nov 4.

Authors

Ashish Sharma¹, Nilesh Kumar^{1

2}, Nikulaa Parachuri¹, Francesco Bandello³, Baruch D Kuppermann⁴

Affiliations

¹ Lotus Eye Hospital and Institute, Coimbatore, India.
² Madhavi Netralaya, Ara, India.
³ University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy.
⁴ Gavin Herbert Eye Institute, University of California, Irvine, California, USA.

PMID: 36332149
DOI: 10.1080/09273948.2022.2139273

No abstract available

Keywords: Drug delivery; pharmacotherapy; retina; sustained release.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Delayed-Action Preparations
Drug Delivery Systems*
Humans
Intravitreal Injections
Retina*

Substances

Delayed-Action Preparations